[New approaches in the chemotherapy of depressive conditions using Anafranil].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000928:Antidepressive Agents / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy; D003863:Depression / Q000188:drug therapy*; D003865:Major Depressive Disorder / Q000188:drug therapy; D004304:Dosage Forms; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D010259:Paranoid Disorders / Q000188:drug therapy; D013927:Thrombosis / Q000139:chemically induced
D000928:Antidepressive Agents; D001552:Benzazepines; D004304:Dosage Forms
Neuartige Wege in der Pharmakotherapie von Verstimmungszuständen mit Anafranil.